Microtissues touts Petri Dish technology for 3D cell culture
Microtissues Inc. of Providence, R.I., may be a relative newcomer to the life sciences industry, but its technology already is garnering attention, first with an artificial ovary that made Time magazine in 2010 and most recently with a 3-D model of a glioma brain tumor.
“Cells grown in 3-D better mimic the complexities of the cell microenvironment,” company President and CEO Jeffrey Morgan told Mass High Tech. Morgan also is associate professor of medical science and co-director of the Center for Biomedical Engineering at Brown University. Morgan developed the technology at Brown, and Microtissues negotiated an exclusive worldwide license to it two years ago, when the company started. The company has fewer than five employees and has an unspecified amount of financing from family, friends, and angels, Morgan said.